MasR deficiency can lead to decreased expression of glucose transporter 4, decreased insulin sensitivity, decreased utilization of glucose in adipose tissue, and decreased tolerance to high glucose, thereby leading to glucose and lipid metabolism disorders and aggravating insulin resistance (39). Here, INS is linked to Disorder of lipid metabolism.